Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C BUTLER

Showing results (1111-1120 of 1,180) with videos related to

Pageof 118
Sort By:
Health Technology Assessment (Winchester, England)|March 24, 2020
C-reactive protein point-of-care testing for safely reducing antibiotics for acute exacerbations of chronic obstructive pulmonary disease: the PACE RCTNick A Francis, David Gillespie, Patrick White, et al.
Frontiers in Medicine|September 27, 2021
Supporting Primary Care Professionals to Stay in Work During the COVID-19 Pandemic: Views on Personal Risk and Access to Testing During the First Wave of Pandemic in EuropeMarta Wanat, Melanie Hoste, Nina Gobat, et al.
Clinical Drug Investigation|July 22, 2021
Direct and Indirect Costs of Influenza-Like Illness Treated with and Without Oseltamivir in 15 European Countries: A Descriptive Analysis Alongside the Randomised Controlled ALIC<sup>4</sup>E TrialXiao Li, Joke Bilcke, Alike W van der Velden, et al.
Antibiotics (Basel, Switzerland)|March 29, 2023
Disease-Specific Quality Indicators for Outpatient Antibiotic Prescribing for Respiratory Infections (ESAC Quality Indicators) Applied to Point Prevalence Audit Surveys in General Practices in 13 European CountriesAkke Vellinga, Addiena Luke-Currier, Nathaly Garzón-Orjuela, et al.
Trials|October 4, 2017
General practitioner use of a C-reactive protein point-of-care test to help target antibiotic prescribing in patients with acute exacerbations of chronic obstructive pulmonary disease (the PACE study): study protocol for a randomised controlled trialJanine Bates, Nick A Francis, Patrick White, et al.
The European Journal of General Practice|May 30, 2023
The experiences of patients ill with COVID-19-like symptoms and the role of testing for SARS-CoV-2 in supporting them: A qualitative study in eight European countries during the first wave of the pandemicMelanie E Hoste, Marta Wanat, Nina Gobat, et al.
Cell Reports|January 25, 2026
A spatial and projection-based transcriptomic atlas of paraventricular hypothalamic cell typesYuxi Li, Trevor C Butler, Stefano Nardone, et al.
Age and Ageing|June 25, 2015
Antibiotic prescribing and associated diarrhoea: a prospective cohort study of care home residentsDavid Gillespie, Kerenza Hood, Antony Bayer, et al.
JAMA|July 8, 2020
Effect of Probiotic Use on Antibiotic Administration Among Care Home Residents: A Randomized Clinical TrialChristopher C Butler, Mandy Lau, David Gillespie, et al.
BMJ Open|June 23, 2019
Protocol for a double-blind placebo-controlled trial to evaluate the efficacy of probiotics in reducing antibiotics for infection in care home residents: the Probiotics to Reduce Infections iN CarE home reSidentS (PRINCESS) trialEleri Owen-Jones, Rachel Lowe, Mark Lown, et al.
Pageof 118

Showing results (1111-1120 of 1,180) with videos related to

Sort By:
Pageof 118
Health Technology Assessment (Winchester, England)|March 24, 2020
C-reactive protein point-of-care testing for safely reducing antibiotics for acute exacerbations of chronic obstructive pulmonary disease: the PACE RCTNick A Francis, David Gillespie, Patrick White, et al.
Frontiers in Medicine|September 27, 2021
Supporting Primary Care Professionals to Stay in Work During the COVID-19 Pandemic: Views on Personal Risk and Access to Testing During the First Wave of Pandemic in EuropeMarta Wanat, Melanie Hoste, Nina Gobat, et al.
Clinical Drug Investigation|July 22, 2021
Direct and Indirect Costs of Influenza-Like Illness Treated with and Without Oseltamivir in 15 European Countries: A Descriptive Analysis Alongside the Randomised Controlled ALIC<sup>4</sup>E TrialXiao Li, Joke Bilcke, Alike W van der Velden, et al.
Antibiotics (Basel, Switzerland)|March 29, 2023
Disease-Specific Quality Indicators for Outpatient Antibiotic Prescribing for Respiratory Infections (ESAC Quality Indicators) Applied to Point Prevalence Audit Surveys in General Practices in 13 European CountriesAkke Vellinga, Addiena Luke-Currier, Nathaly Garzón-Orjuela, et al.
Trials|October 4, 2017
General practitioner use of a C-reactive protein point-of-care test to help target antibiotic prescribing in patients with acute exacerbations of chronic obstructive pulmonary disease (the PACE study): study protocol for a randomised controlled trialJanine Bates, Nick A Francis, Patrick White, et al.
The European Journal of General Practice|May 30, 2023
The experiences of patients ill with COVID-19-like symptoms and the role of testing for SARS-CoV-2 in supporting them: A qualitative study in eight European countries during the first wave of the pandemicMelanie E Hoste, Marta Wanat, Nina Gobat, et al.
Cell Reports|January 25, 2026
A spatial and projection-based transcriptomic atlas of paraventricular hypothalamic cell typesYuxi Li, Trevor C Butler, Stefano Nardone, et al.
Age and Ageing|June 25, 2015
Antibiotic prescribing and associated diarrhoea: a prospective cohort study of care home residentsDavid Gillespie, Kerenza Hood, Antony Bayer, et al.
JAMA|July 8, 2020
Effect of Probiotic Use on Antibiotic Administration Among Care Home Residents: A Randomized Clinical TrialChristopher C Butler, Mandy Lau, David Gillespie, et al.
BMJ Open|June 23, 2019
Protocol for a double-blind placebo-controlled trial to evaluate the efficacy of probiotics in reducing antibiotics for infection in care home residents: the Probiotics to Reduce Infections iN CarE home reSidentS (PRINCESS) trialEleri Owen-Jones, Rachel Lowe, Mark Lown, et al.
Pageof 118